FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Jefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining a Buy rating. The upgrade cycle for NexSys appears underway with several customers launching trials in September while full market release mid-next year assumes new contracts are in place.
The... More

